Trial Library and American Oncology Network Partner to Expand Patient Access to Cancer Clinical Trials

San Francisco, CA, March 12, 2025 Trial Library, a leader in AI-enabled clinical trial matching and patient navigation with a strong reputation in oncology, has partnered with American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, to enhance patient identification and recruitment for oncology clinical trials. The collaboration aims to expand trial access for patients with various cancers, including breast and lung cancer.

As part of the partnership, Trial Library is embedded in three AON-affiliated practices across 10 locations: Oncology Hematology Associates (Missouri), Zangmeister Cancer Center (Ohio), and Messino Cancer Centers (North Carolina). Trial Library’s patient identification and navigation platforms allow AON providers to efficiently identify eligible patients and connect them with appropriate clinical trial opportunities.

“Clinical trials are essential to advancing cancer treatment, yet many patients face barriers to participation,” said Katie Goodman, RN, vice president of clinical research at American Oncology Network. “Partnering with Trial Library streamlines the trial identification process, reducing the burden on providers, and ensuring more patients have access to innovative therapies that could change their lives.”

Trial Library’s patient identification platform has accelerated trial enrollment at AON locations by identifying tens of eligible patients for solid tumor trials in the first quarter since launch. The AON – Trial Library collaboration is reducing administrative burden on providers and transforming how community oncology practices engage with clinical research. For more information about Trial library, visit triallibrary.com. For more information about AON visit aoncology.com.

About Trial Library
Trial Library is a technology company that supports accelerated and equitable recruitment to oncology clinical trials. Trial Library’s evidence-based, provider- facing software is integrated with technology-enabled patient navigation. For more information about Trial Library, visit triallibrary.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Woodlands Cancer Institute Relocates Its Medical Oncology Clinic in The Woodlands, Texas

Local oncology practice moves to a new location to continue providing enhanced cancer care to The Woodlands, Texas community.

The Woodlands, TX, March 4, 2025 – Woodlands Cancer Institute, a partner practice of American Oncology Network (AON), has relocated its medical oncology clinic in The Woodlands to 18354 I-45 South, Suite 200. Current or prospective patients can call (936) 235-7092 for inquiries or to schedule an appointment. Woodlands Cancer Institute’s radiation oncology services will continue to be provided at: 135 Vision Park Blvd., The Woodlands, TX 77384, and patients who receive medical oncology care at the Conroe clinic located at 603 Conroe Medical Drive, Suite 160, may continue to do so at that location.

Board-certified medical oncologists Eric P. Kleinbaum, MD, Sandeep “Kodi” Kodityal, MD, FACP, and Krishna K. Pachipala, MD, MRCP are now accepting patients at the new medical oncology clinic location. The new clinic includes additional private exam rooms that provide dedicated space for patient-physician conversations, an infusion room, in-house lab and pathology services, and a specialty pharmacy for oral oncolytics.

“Our medical oncology practice location in The Woodlands has moved, but our standards of patient care have not changed,” said Dr. Kodityal. “We hold ourselves to a high standard of continuously providing exceptional, compassionate care that is central to our patient-first mindset, and is the standard in all of Woodlands Cancer Institute’s clinic locations. We appreciate our patients’ continued trust and look forward to serving them at our new medical oncology clinic address in The Woodlands.”

Woodlands Cancer Institute provides care to patients living in The Woodlands and surrounding areas. The practice ensures patients receive personalized care and treatment plans that are designed exclusively for their unique needs. As a community-based practice, Woodlands Cancer Institute provides affordable care in a comfortable environment while offering high-quality, state-of-the-art treatment in convenient locations.

The practice is a partner of American Oncology Network, one of the nation’s fastest-growing community-based oncology networks. Through this partnership, American Oncology Network makes additional patient care and services available such as access to the in-house specialty pharmacy with home delivery of certain medications among other benefits.

“We are excited to welcome our patients to the new space,” said Dr. Kodityal. “The relocation will allow us to expand patient services and therapeutics, while also providing a larger space for additional staff to continue prioritizing patients’ health and well-being by providing individualized, personal care.”

For more information about AON, visit AONcology.com. For more information about Woodlands Cancer Institute, visit woodlandscancer.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Woodlands Cancer Institute
Woodlands Cancer Institute is a community-based medical oncology, radiation oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, the practice strives to provide the best possible experience to patients and their families throughout their healthcare journey. Learn more at woodlandscancer.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Network Launches Cloud‑Based Laboratory Information System to Streamline Pathology Reporting for Oncologists

SigmaCore’s easy-to-use platform, LabVizor integrates complex pathology reports into a streamlined, comprehensive system to enhance efficiency for AON’s pathology and oncology labs.

FORT MYERS, FL., Feb. 25, 2025  American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, is proud to announce the launch of LabVizor (LV), an advanced cloud-based anatomic pathology laboratory information system (LIS) developed by pathology practice management consultancy, SigmaCore. This marks a significant milestone in AON’s ongoing commitment to delivering pathology solutions to improve cancer diagnosis, reporting, and patient care.

LabVizor, the product of over 12 years of development by industry experts, is a HIPAA-compliant LIS designed specifically for the unique needs of oncologists and pathologists. Founded by hematopathologist Dr. Aamir Ehsan and Atiq Malik, Executive Vice President of IT at SigmaCore, LabVizor offers an easy-to-use platform that integrates complex pathology reports into a streamlined, comprehensive system for hematopathology and oncology, focusing on operational excellence and efficiency for pathology and oncology labs worldwide.

“We are thrilled that AON has chosen LabVizor to enhance its diagnostic workflows,” said Dr. Aamir Ehsan, CEO of SigmaCore. “Our platform is designed to improve operational efficiency across all levels – from the lab to clinical decision-making – and we are excited to see how AON’s teams will benefit from its seamless integration, whether it’s an oncologist reviewing test results or a laboratory manager optimizing workflows.”

LabVizor is fully integrated with  AON’s electronic medical record (EMR) system, enabling bidirectional data exchange. This integration allows oncology teams to access complex and individual reports with ease, including those for bone marrow morphology, digital pathology, flow cytometry, cytogenetics, FISH analysis, and Next-Generation Sequencing (NGS). These reports are presented in an intuitive, easy-to-read format, helping oncologists make faster and more accurate clinical decisions. With its cloud-based infrastructure, LabVizor offers scalability and flexibility, ensuring that AON’s network can continue to evolve and grow.

Key features of LabVizor include:

  • Pre-Accessioning: A powerful feature that helps laboratories plan workflows and improve sample accountability, reducing the risk of lost samples.
  • Integrated Reporting: Seamless presentation of complex diagnostic information, from test orders and add-ons to detailed reports and results.
  • User-Friendly Dashboard: A modern, customizable dashboard that provides users with a comprehensive view of lab operations, including QA metrics, turnaround time (TAT) monitoring, and real-time performance tracking.
  • Prefix based customization of reports
  • Data Analytics: LabVizor offers internal and external data elements that support clinical guidelines, revenue monitoring, and clinical trial insights, empowering users to generate meaningful data-driven reports.
  • Collaboration Tools: Built-in chat and comment features, co-signatures, and easy communication among team members for more effective workflow management.

“AON is committed to leveraging cutting-edge technology to enhance cancer care and streamline workflows for our providers,” said AON CEO Todd Schonherz. “Integrating LabVizor aligns with our mission to provide efficient, high-quality, patient-centered oncology services. By equipping our teams with this advanced system, we are improving diagnostic accuracy and ensuring oncologists have seamless access to critical pathology insights, ultimately benefiting the patients we serve.”

“We are delighted to announce the integration of LabVizor,” said Mark Moch, American Oncology Network’s chief information officer. “Launching a laboratory information system that utilizes the latest advanced technology to improve cancer diagnosis, reporting, and patient care is a significant milestone in our ongoing commitment to expanding access to high-quality, patient-first cancer care in local communities nationwide.”

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About SigmaCore
SigmaCore is a pathology practice management consultancy that offers a unique and innovative approach to empowering pathologists – whether working solo or in small or large group practices. SigmaCore has created a platform by pathologists for pathologists to build, manage and optimize pathology practices everywhere. For more information, please visit Sigmacore.us.

About LabVizor
LabVizor is a cloud-based anatomic pathology laboratory information system (LIS) designed to meet the needs of pathologists and oncologists. Developed by SigmaCore, LabVizor combines advanced diagnostic reporting, seamless integration with EMRs, and powerful data analytics to support healthcare providers in delivering superior cancer care. As the flagship product of SigmaCore, LabVizor underscores the company’s commitment to delivering LIS solutions that meet the evolving needs of modern pathology and oncology. For more information, please visit sigmacore.us/lab-informatics/.

Media Contacts

SigmaCore  
Celina Perkins
cperkins@sigmacore.us | 210-355-1284

American Oncology Network
Karen Riley Sawyer
Karen.sawyer@AONcology.com | 541-221-1472

Florida Oncology and Hematology and American Oncology Network Welcome Dr. Michele Ramirez

NAPLES, FL., January 23, 2025 — Community oncology practice Florida Oncology and Hematology (FOH), a partner practice of American Oncology Network (AON), is pleased to welcome Board-certified medical oncologist and hematologist Michele Ramirez, MD, to its physician care team. Dr. Ramirez is now accepting patients at Naples Community Hospital (NCH) Baker Hospital Downtown and Naples Community Hospital (NCH) North Naples Hospital. Patients will be referred to FOH practice locations in alignment with their individual treatment plans.

Dr. Ramirez is a Board-certified oncologist and hematologist serving patients in Naples, Florida. She has more than 20 years of experience and has been practicing in Florida since 2002. She earned her medical degree from Cornell University Medical College in New York, completed her internal medicine residency at Case Western Reserve University in Cleveland, Ohio, and completed a fellowship in hematology-oncology at the same institution.

“I am excited to join the physician team at Florida Oncology and Hematology,” said Dr. Ramirez. “My goal has always been to provide the best patient-centered care possible – nothing less than I would want for my own family. I look forward to collaborating with their like-minded team.”

The Florida Oncology and Hematology team now includes eight medical oncologists and 10 advanced practice providers across five Florida locations. The practice is committed to providing the community with innovative cancer care that is delivered holistically based on research and evidence-based medicine. FOH cancer patients have access to a diverse range of services for diagnosis, treatment, clinical trials, survivorship, and patient support that are close to home, eliminating the need to travel long distances to receive care.

“We are excited to welcome Dr. Ramirez to Florida Oncology and Hematology,” said Zanetta Lamar, MD, medical oncologist and hematologist at FOH. “She is extraordinarily knowledgeable and committed to delivering top-notch patient-first care, which will further enhance our ability to offer an exceptional patient experience in Naples. We are thrilled to have her partner with our Florida Oncology and Hematology team.”

“On behalf of AON, I am pleased to welcome Dr. Ramirez to Florida Oncology and Hematology, and the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Dr. Ramirez has an impressive background, and I am confident that our patients – and our team – will benefit immensely from her expertise and commitment to providing quality, patient-centered care.”

For more information about AON, visit AONcology.com. For more information about Florida Oncology and Hematology visit floridaonc.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Florida Oncology and Hematology
Specialists in the diagnosis and treatment of cancer and blood disorders, Florida Oncology and Hematology serves patients in Cape Coral, Clearwater, Fort Myers, and Naples, Florida. As a community-based practice, Florida Oncology and Hematology offers a full range of exceptional cancer services, providing the highest quality treatments based on research and focused on the whole person. Learn more at floridaonc.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

MidAmerica Cancer Care Joins American Oncology Network

KANSAS CITY, MO., January 22, 2025 –MidAmerica Cancer Care (MACC), a trusted name in Kansas City and western Missouri cancer care, is proud to announce it has joined American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices.

This partnership enables MACC to expand its patient-focused services, grow its clinical trial offerings, and pursue new market opportunities, while continuing to provide the high-quality, compassionate care that has been a hallmark of the practice since it opened in 2019.

“We are excited to partner with American Oncology Network,” said Dr. Jaswinder Singh, a Board-certified medical oncologist and hematologist at MACC. “Both MACC and AON are dedicated to providing innovative, high-quality, and personalized cancer care in a community setting. This collaboration enhances our ability to deliver advanced treatments while preserving the patient-centered approach that our patients rely on. We look forward to offering expanded services through this partnership, making care more convenient and improving outcomes for those we serve.” 

MACC provides community-based oncology services to patients in the Kansas City metropolitan area and western Missouri and is staffed by six Board-certified medical oncologists and 16 advanced practitioners. MACC offers comprehensive cancer care, including diagnostics, treatment, clinical trials, survivorship programs, and patient support – all delivered close to home to reduce travel burdens for patients and their families. MACC clinics feature private exam rooms and on-site infusion suites designed for patient comfort and privacy during treatment.

“We are pleased to welcome MidAmerica Cancer Care to the American Oncology Network,” said  Todd Schonherz, AON’s chief executive officer. “MACC is known for its exceptional patient-centered, community-based care, and their team’s extensive expertise aligns perfectly with AON’s mission to deliver individualized cancer care tailored to each patient’s unique needs. This partnership not only supports our goal of expanding access to high-quality, patient-first cancer care in local communities nationwide but also demonstrates AON’s ability to collaborate with both physician groups and hospital systems. By working alongside local health systems, we can further enhance community oncology in Kansas City and beyond. We are eager to collaborate and benefit from the expertise MACC providers bring to our network.”

“On behalf of AON, I am delighted to welcome the MACC team to the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Their dedication to providing quality care in a community setting has made a significant impact in western Missouri. I am confident their expertise and commitment will greatly enhance the care we provide to patients and strengthen our team across the network.”

MACC providers are now accepting new patients. For more information about AON, visit AONcology.com. To learn more about MidAmerica Cancer Care, visit maccsp.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About MidAmerica Cancer Care
Established in 2019, MidAmerica Cancer Care (MACC) has one central mission: to provide compassionate cancer care to patients right in their own communities. Because tumors and cancers are unique, it is important to create a unique treatment plan for each patient. At MACC, treating the whole patient and not just the cancer itself, is an integral part of this approach. This is accomplished through leading-edge programs and technologies delivered in a highly personal and compassionate setting.

MidAmerica Cancer Care has six physicians and 16 advanced practitioners on staff, in 9 locations. With more than 50 years combined experience, MACC is dedicated to fighting for each patient as if they are family.

With its main location on the campus of St. Joseph Medical Center in Kansas City, MO, MACC visits with patients in multiple locations. Learn more at maccsp.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Florida Oncology and Hematology Relocates Fort Myers Clinic

Local oncology practice moves to a new state-of-the-art location to continue providing enhanced cancer care to the Fort Myers community.

FORT MYERS, FL, Jan. 21, 2025 – Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its clinic in Fort Myers to 14551 Hope Center Loop. The newly expanded clinic includes 12 exam rooms, nearly 30 infusion chairs, and an onsite lab. Current or prospective patients can call (239) 264-7026 for inquiries or to schedule an appointment.

Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO are now accepting patients at the new Fort Myers location. The new clinic includes additional private exam rooms that provide dedicated space for patient-physician conversations, an infusion room, in-house lab and pathology services, and an onsite specialty pharmacy for oral oncolytics.

“Our Fort Myers practice location has moved, but our standards of patient care have not changed,” said medical director, Dr. Van den Bergh. “We hold ourselves to a high standard of continuously providing exceptional, compassionate care that is central to our patient-first mindset, and is the standard in all of Florida Oncology and Hematology’s five clinic locations. We appreciate our patients’ continued trust and look forward to serving them at our new address in Fort Myers.”

Florida Oncology and Hematology provides care to patients living in Cape Coral, Clearwater, Fort Myers, Naples, and surrounding areas. The practice ensures patients receive personalized care and treatment plans that are designed exclusively for their unique needs. As a community-based practice, Florida Oncology and Hematology provides affordable care in a comfortable environment while offering high-quality, state-of-the-art treatment in convenient locations.

The practice is a partner of American Oncology Network, one of the nation’s fastest-growing community-based oncology networks. Through this partnership, American Oncology Network makes additional patient care and services available such as access to the in-house specialty pharmacy with home delivery of certain medications among other benefits.

“We are excited to welcome our patients to the new space, where we will continue to prioritize their health and well-being,” said Dr. Van den Bergh. “The relocation will allow us to expand patient services and therapeutics, while also providing a larger space for additional staff to deliver one-on-one care.”

For more information about AON, visit AONcology.com. For more information about Florida Oncology and Hematology, visit floridaonc.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Florida Oncology and Hematology

Specialists in the diagnosis and treatment of cancer and blood disorders, Florida Oncology and Hematology serves patients in Cape Coral, Clearwater, Fort Myers, and Naples, Florida. As a community-based practice, it offers a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at floridaonc.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Network Appoints Charlie Goddard as General Counsel

FORT MYERS, Fla., Jan. 15, 2025 – American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced the appointment of Charlie Goddard as General Counsel.

“We are pleased to welcome Charlie to the AON leadership team,” said Todd Schonherz, AON’s chief executive officer. “Charlie has built an impressive legal career, and his healthcare expertise makes him a perfect fit for this essential role. His deep knowledge of health law will be invaluable as we continue to grow AON.”

Goddard brings more than 15 years of legal experience in healthcare law, corporate governance, and compliance. His expertise includes fraud and abuse prevention, data privacy and cyber security, dispute resolution, and the negotiation and execution of high-stakes commercial transactions.

“I am honored to join AON’s executive team,” said Goddard. “AON’s mission to make cancer care affordable and accessible in communities across the country is inspiring. I am excited to bring my expertise to the team, work collaboratively, and build meaningful relationships to drive positive outcomes for our patients and providers.”

“The healthcare landscape is constantly evolving, creating new opportunities and challenges that require the expertise Charlie brings,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “I am confident Charlie will serve as a valuable strategic partner, helping us navigate complexities while advancing our strategic initiatives.”

Prior to joining AON, Goddard held positions at an AmLaw 100 firm and served as general counsel for a leading orthopedic surgery group. He is a graduate of the Florida State University College of Law and is licensed to practice in all Florida state courts and the U.S. District Court for the Middle District of Florida.

For more information about AON, visit AONcology.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Fort Wayne Medical Oncology and Hematology Joins American Oncology Network

FORT WAYNE, IN., January 7, 2025 – Fort Wayne Medical Oncology and Hematology (FWMOH), a trusted name in northeastern Indiana cancer care since 1977, is proud to announce it has joined American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices.

This partnership enables FWMOH to expand its patient-focused services while continuing the high-quality, compassionate care that has been a hallmark of the practice for nearly five decades.

“We are thrilled to join American Oncology Network,” said Dr. Praveen Kollipara, a Board-certified medical oncologist and president of FWMOH. “This partnership comes at an exciting time for FWMOH. We’ve recently added the leading gynecologic oncologists in northeastern Indiana and expanded our presence in Peru and Warsaw. With AON’s support, we will pursue additional growth initiatives and innovations to enhance care for more patients in the region.”

FWMOH operates ten locations across northeastern Indiana and is staffed by 16 Board-certified medical oncologists and two Board-certified gynecologic oncologists, Dr. Iwona Podzielinski and Dr. Scott Goodrich, who joined AON as Fort Wayne Gynecologic Oncology, a division of FWMOH, in November in anticipation of the FWMOH/AON partnership.

“We are excited to join FWMOH as its gynecologic oncology division,” said Dr. Podzielinski. “FWMOH and AON share a deep commitment to delivering innovative, high-quality, and personalized cancer care in a community setting. This partnership strengthens our ability to offer cutting-edge treatments while maintaining the patient-centered approach our patients trust. We look forward to the expanded services this collaboration will bring, enhancing convenience and improving outcomes for the patients we serve.” 

FWMOH offers comprehensive cancer care, including laboratory services, PET/CT imaging, diverse oral and IV infusion treatment options, clinical trials, survivorship programs, and patient support – all delivered close to home to reduce travel burdens for patients and their families. FWMOH clinics feature private exam rooms and on-site infusion suites designed for patient comfort and privacy during treatment.

“We are pleased to welcome Fort Wayne Medical Oncology and Hematology to the American Oncology Network,” said AON’s chief executive officer Todd Schonherz. “FWMOH is ASCO certified and has an exceptional reputation for delivering patient-centered, community-based care. Their team brings extensive expertise and shares AON’s commitment to individualized care tailored to each patient’s unique needs. This partnership aligns with AON’s mission to expand access to high-quality, patient-first cancer care in local communities nationwide. We look forward to the expertise FWMOH providers bring to our network.”

“On behalf of AON, I am thrilled to welcome the FWMOH team to the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “The FWMOH team has delivered exceptional care in northeastern Indiana for decades, and I am confident that our patients – and our team – will benefit immensely from their expertise and commitment to providing quality, patient-centered care in a community-based setting.”

FWMOH providers are now accepting new patients. For more information about AON, visit AONcology.com. To learn more about Fort Wayne Medical Oncology and Hematology, visit fwmoh.com.

###

About Fort Wayne Medical Oncology and Hematology
Fort Wayne Medical Oncology and Hematology (FWMOH) provides state-of-the-art cancer and blood disorder treatments through a team of dedicated healthcare providers serving northeastern Indiana. Since 1977, FWMOH has cared for thousands of patients, treating more than 40 types of cancer – from bladder to bone, pancreatic to prostate – as well as blood disorders such as hemophilia, sickle cell anemia, and idiopathic thrombocytopenic purpura (ITP).

FWMOH’s experienced physicians, nurse practitioners, nurses, and clinical support staff work collaboratively to deliver the high-quality oncologic and hematologic care informed by cutting-edge research and decades of experience. The team emphasizes compassionate, patient-centered care that respects the needs of the whole person.

The following Board-certified physicians are accepting appointments at FWMOH: Farrukh M. Adhami, MD; Sunil Babu, MD; Matthew L. Carr, MD; Shalini Chitneni, MD; Michael Epstein, MD; Gary G. Gize, MD; Ryan Gonzales, MD; Praveen Kollipara, MD; Yasolatha Nalamolu, MD; Screenivasa R. Nattam, MD; Dolly Rosa Quispe, MD; Steven N. Rhinehart, MD; Ahad Sadiq, MD; Naga Vutukuri, MD; Richard Zhang, MD; and David M. Zimmerman, MD. FWMOH’s gynecologic oncologists include Dr. Iwona Podzielinski and Dr. Scott Goodrich.

Learn more at fwmoh.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Cancer and Blood Specialists of Arizona and American Oncology Network Welcome Dr. Ronak Rakesh Shah

Board-certified medical oncologist Ronak Rakesh Shah, DO, joins the physician team

CASA GRANDE, AZ., January 2, 2025 — Community oncology practice Cancer and Blood Specialists of Arizona (CBSA), a partner practice of American Oncology Network (AON) (OTCQX: AONC), is pleased to welcome Board-certified medical oncologist Ronak Rakesh Shah, DO, to its physician care team. Dr. Shah is now accepting patients at the Casa Grande clinic.

Dr. Shah is a Board-certified medical oncologist and hematologist. He earned his medical degree from Michigan State University College of Osteopathic Medicine, completed his residency at McLaren Macomb Hospital, and completed a fellowship in hematology and oncology at Larkin Community Hospital, an affiliate of Nova Southeastern University in Hialeah, Florida.

“I am excited to join the physician team at Cancer and Blood Specialists of Arizona,” said Dr. Shah. “CBSA is known for providing innovative and exceptional patient-centered care – the kind that I pride myself on delivering – and I can’t wait to collaborate with the like-minded team.”

The Cancer and Blood Specialists of Arizona team now includes two medical oncologists, a radiation oncologist, a general surgeon, and three advanced practice providers across two Arizona locations. The practice is committed to providing the community with innovative cancer care that is delivered holistically based on research and evidence-based medicine. CBSA cancer patients have access to a diverse range of services for diagnosis, treatment, clinical trials, survivorship, and patient support that are close to home, eliminating the need to travel long distances to receive care.

“We are excited to welcome Dr. Shah to Cancer and Blood Specialists of Arizona,” said Carlos E. Arce-Lara, MD, medical oncologist and hematologist at CBSA. “He is extraordinarily knowledgeable and committed to delivering top-notch patient-first care, which will further enhance our ability to offer an exceptional patient experience here in Arizona. We are thrilled to have him join our Cancer and Blood Specialists of Arizona team.”

“On behalf of AON, I am pleased to welcome Dr. Shah to Cancer and Blood Specialists of Arizona, and the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Dr. Shah’s background is impressive, and I am confident that our patients – and our team – will benefit immensely from his expertise and commitment to providing quality, patient-centered care in a community-based setting.”

For more information about AON, visit AONcology.com. For more information about Cancer and Blood Specialists of Arizona visit cancerbloodspecialistsaz.com.

###

About American Oncology Network
American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Cancer and Blood Specialists of Arizona

We are experienced physicians, nurse practitioners, nurses and clinical support staff who work collaboratively with our administrative support care team to provide compassionate, patient-centered care. With more than 40 years of collective experience in Casa Grande and Flagstaff areas, our physicians have a history of delivering the highest quality oncologic and hematologic care treatment that is based on cutting-edge research and experience. We work together as a team providing care with empathy, respect, and consideration of what is best for the whole person throughout their cancer fight. As each cancer journey is unique, we deliver the most advanced and innovative treatments tailored to every patient for the best possible outcome and experience. Learn more at cancerbloodspecialistsaz.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting

INDIANAPOLIS, IN., Dec. 30, 2024 — Board-certified medical oncologists, M. Sarfraz Nawaz, MD and Ruemu E. Birhiray, MD from community oncology practice Hematology Oncology of Indiana (HOI), a partner practice of American Oncology Network (AON) (OTCQX: AONC), presented clinically meaningful and socially impactful research findings at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, held Dec. 7-10 in San Diego.

The ASH Annual Meeting is recognized as a premier event for hematology research, with more than 5,000 scientific abstracts submitted each year. Accepted abstracts undergo rigorous peer review, with selected presentations showcasing significant and innovative contributions to the field.

The following HOI physician-researchers presented at the conference:

“Being selected to present research at the ASH Annual Meeting is a significant honor,” said Dr. M. Sarfraz Nawaz. “With thousands of submissions considered, these selected abstracts highlight vital advancements in cancer care. I congratulate my colleagues on their achievements and dedication to improving patient outcomes.”

“The evolving field of cancer research continually brings transformative findings that revolutionize patient care,” said Stephen “Fred” Divers, MD, AON chief medical officer. “Our physicians’ commitment to ongoing education and innovation reflects their dedication to advancing cancer care through impactful research that improves patient outcomes and expands access to quality care.”

###

American Oncology Network
American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Hematology Oncology of Indiana

Hematology Oncology of Indiana is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, Hematology Oncology of Indiana strives to provide the best possible experience to patients and their families throughout the healthcare journey. Learn more at hematologyoncology.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com